Showing results (131-140 of 843) with videos related to
Sort By:
Pageof 85
Clinics in Liver Disease|April 6, 2019
Hepatic Complications of Inflammatory Bowel DiseaseMahmoud Mahfouz, Paul Martin, Andres F CarrionPublic Understanding of Science (Bristol, England)|March 7, 2014
The changing brain: Neuroscience and the enduring import of everyday experienceMartyn Pickersgill, Paul Martin, Sarah Cunningham-BurleyExpert Opinion on Pharmacotherapy|February 11, 2015
Dasabuvir : a new direct antiviral agent for the treatment of hepatitis CJuan Pablo Trivella, Julio Gutierrez, Paul MartinJournal of Medical Virology|August 15, 2015
Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysisFabrizio Fabrizi, Vivek Dixit, Paul Martin, et al.Gastroenterology & Hepatology|September 5, 2017
Advances and Future Directions in the Treatment of Hepatocellular CarcinomaAshil J Gosalia, Paul Martin, Patricia D JonesJournal of Nephrology|January 22, 2004
Transplantation of kidneys from HCV-positive donors: a safe strategy?Fabrizio Fabrizi, Suphamai Bunnapradist, Giovanna Lunghi, et al.Clinics in Liver Disease|April 26, 2025
Long-Term Care of the Liver Transplant RecipientAndrew R Scheinberg, Paul Martin, Joshua A TurkeltaubJournal of Nephrology|December 31, 2003
Kinetics of hepatitis C virus load during hemodialysis: novel perspectivesFabrizio Fabrizi, Suphamai Bunnapradist, Giovanna Lunghi, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 23, 2015
Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-AnalysisFabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, et al.Nature Reviews. Genetics|September 17, 2004
Integrating pharmacogenetics into society: in search of a modelAndrew Webster, Paul Martin, Graham Lewis, et al.Pageof 85